{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:04:10Z","timestamp":1758477850507},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Visceral Surgery"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jviscsurg.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T02:15:42Z","timestamp":1509761742000},"page":"183-189","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin"],"prefix":"10.1016","volume":"155","author":[{"given":"G.","family":"Miailhe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Arfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mirshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jviscsurg.2017.10.008_bib0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jviscsurg.2017.10.008_bib0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jviscsurg.2017.10.008_bib0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jviscsurg.2017.10.008_bib0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1634\/theoncologist.2008-0275","article-title":"The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer","volume":"14","author":"Helm","year":"2009","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.jviscsurg.2017.10.008_bib0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jso.21519","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and\/or peritoneal carcinomatosis: results from a Chinese center","volume":"101","author":"Yang","year":"2010","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.jviscsurg.2017.10.008_bib0180","first-page":"256","article-title":"Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications","volume":"31","author":"Dovern","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"issue":"11","key":"10.1016\/j.jviscsurg.2017.10.008_bib0185","first-page":"3944","article-title":"Selective lethal effect of supranormal temperatures on human neoplastic cells","volume":"36","author":"Giovanella","year":"1976","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.jviscsurg.2017.10.008_bib0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1994.45","article-title":"Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin","volume":"69","author":"Los","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jviscsurg.2017.10.008_bib0195","first-page":"CD005340","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","volume":"1","author":"Jaaback","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jviscsurg.2017.10.008_bib0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1245\/ASO.2004.09.008","article-title":"Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials","volume":"11","author":"Elias","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.jviscsurg.2017.10.008_bib0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jso.23464","article-title":"Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models","volume":"109","author":"Gremonprez","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2017.10.008_bib0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-2215-4-9","article-title":"Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"4","author":"Muenyi","year":"2011","journal-title":"J Ovarian Res"},{"issue":"5","key":"10.1016\/j.jviscsurg.2017.10.008_bib0215","doi-asserted-by":"crossref","first-page":"730-7","DOI":"10.1097\/SLA.0b013e3182737517","article-title":"New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models","volume":"256","author":"Lehmann","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.jviscsurg.2017.10.008_bib0220","first-page":"39","article-title":"Gene expression changes induced by HIPEC in a murine model of gastric cancer","volume":"26","author":"Graziosi","year":"2012","journal-title":"Vivo Athens Greece"},{"issue":"1","key":"10.1016\/j.jviscsurg.2017.10.008_bib0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0b013e3182193143","article-title":"Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model","volume":"254","author":"Pich\u00e9","year":"2011","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.jviscsurg.2017.10.008_bib0230","first-page":"40","article-title":"Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III\/IV ovarian cancer (from the Gynecologic Oncology Group)","volume":"23","author":"McGuire","year":"1996","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2017.10.008_bib0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2000.18.1.106","article-title":"Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study","volume":"18","author":"Muggia","year":"2000","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.jviscsurg.2017.10.008_bib0240","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2017.10.008_bib0245","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.1992.10.5.706","article-title":"Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer","volume":"10","author":"Alberts","year":"1992","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2017.10.008_bib0250","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2017.10.008_bib0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jso.21078","volume":"98","author":"Sugarbaker","year":"2008","journal-title":"J Surg Oncol"},{"issue":"26","key":"10.1016\/j.jviscsurg.2017.10.008_bib0260","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jviscsurg.2017.10.008_bib0265","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jviscsurg.2017.10.008_bib0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jviscsurg.2017.10.008_bib0275","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2017.10.008_bib0280","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0277-5379(91)90389-U","article-title":"Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats","volume":"27","author":"Los","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"5","key":"10.1016\/j.jviscsurg.2017.10.008_bib0285","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1053\/j.gastro.2008.02.098","article-title":"Systemic treatment of colorectal cancer","volume":"134","author":"Wolpin","year":"2008","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jviscsurg.2017.10.008_bib0290","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.jviscsurg.2017.10.008_bib0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jso.20013","article-title":"Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"85","author":"Verwaal","year":"2004","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.jviscsurg.2017.10.008_bib0300","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","article-title":"Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique","volume":"6","author":"Stephens","year":"1999","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Visceral Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187878861730125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187878861730125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T09:22:07Z","timestamp":1654075327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187878861730125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S187878861730125X"],"URL":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2017.10.008","relation":{},"ISSN":["1878-7886"],"issn-type":[{"value":"1878-7886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin","name":"articletitle","label":"Article Title"},{"value":"Journal of Visceral Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}